---
title: "Energy Peptides | PepTracker Pro"
url: https://peptrackerpro.com/benefits/energy
description: "Peptides studied for cellular energy production and metabolic vitality."
lang: en
---

Skip to main content

**Educational information only.** This site does not provide medical advice. Read full disclaimer (https://peptrackerpro.com/disclaimer)

# Energy Peptides

Peptides studied for cellular energy production and metabolic vitality.

### 5-Amino-1MQ

Low Evidence

A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction.

Fat Loss: https://peptrackerpro.com/benefits/fat-loss
Metabolism: https://peptrackerpro.com/benefits/metabolism
Energy: https://peptrackerpro.com/benefits/energy

View Details: https://peptrackerpro.com/peptides/5-amino-1mq

\+ Compare: https://peptrackerpro.com/compare?select=5-amino-1mq
Track in App: https://app.peptrackerpro.com/?add=5-amino-1mq

### Apelin

Medium Evidence

An endogenous cardiovascular peptide that signals through the APJ receptor, studied for heart failure, cardiac repair, and cardioprotection with multiple synthetic analogs in clinical development.

Recovery: https://peptrackerpro.com/benefits/recovery
Inflammation: https://peptrackerpro.com/benefits/inflammation
Energy: https://peptrackerpro.com/benefits/energy

View Details: https://peptrackerpro.com/peptides/apelin

\+ Compare: https://peptrackerpro.com/compare?select=apelin
Track in App: https://app.peptrackerpro.com/?add=apelin

### GDF-15 Receptor Agonists

Medium Evidence

A new class of peptide-based weight loss therapeutics that act through the GFRAL/RET receptor in the brainstem, representing a non-GLP-1 mechanism for appetite suppression and energy expenditure regulation.

Weight Management (https://peptrackerpro.com/benefits/weight-management)Appetite Regulation (https://peptrackerpro.com/benefits/appetite-regulation)Fat Loss (https://peptrackerpro.com/benefits/fat-loss)Metabolism (https://peptrackerpro.com/benefits/metabolism)+1 more

View Details: https://peptrackerpro.com/peptides/gdf15-agonists

\+ Compare: https://peptrackerpro.com/compare?select=gdf15-agonists
Track in App: https://app.peptrackerpro.com/?add=gdf15-agonists

### LIPO-C

Low Evidence

A lipotropic injection blend containing methionine, inositol, choline, and other compounds to support fat metabolism.

View Details: https://peptrackerpro.com/peptides/lipo-c

\+ Compare: https://peptrackerpro.com/compare?select=lipo-c
Track in App: https://app.peptrackerpro.com/?add=lipo-c

### MOTS-c

Low Evidence

A mitochondrial-derived peptide studied for metabolic regulation, exercise mimetic effects, and longevity.

Metabolism (https://peptrackerpro.com/benefits/metabolism)Fat Loss (https://peptrackerpro.com/benefits/fat-loss)Longevity (https://peptrackerpro.com/benefits/longevity)Muscle Growth (https://peptrackerpro.com/benefits/muscle-growth)+2 more

View Details: https://peptrackerpro.com/peptides/mots-c

\+ Compare: https://peptrackerpro.com/compare?select=mots-c
Track in App: https://app.peptrackerpro.com/?add=mots-c

### NAD+

Medium Evidence

A coenzyme essential for cellular energy production, studied for anti-aging and metabolic support.

Energy (https://peptrackerpro.com/benefits/energy)Longevity (https://peptrackerpro.com/benefits/longevity)Anti-Aging (https://peptrackerpro.com/benefits/anti-aging)Metabolism (https://peptrackerpro.com/benefits/metabolism)+1 more

View Details: https://peptrackerpro.com/peptides/nad

\+ Compare: https://peptrackerpro.com/compare?select=nad
Track in App: https://app.peptrackerpro.com/?add=nad

### SLU-PP-332

Low Evidence

A synthetic ERRα/β/γ pan-agonist studied as an 'exercise mimetic' for endurance, fat oxidation, and metabolic health.

Energy: https://peptrackerpro.com/benefits/energy
Fat Loss: https://peptrackerpro.com/benefits/fat-loss
Metabolism: https://peptrackerpro.com/benefits/metabolism

View Details: https://peptrackerpro.com/peptides/slu-pp-332

\+ Compare: https://peptrackerpro.com/compare?select=slu-pp-332
Track in App: https://app.peptrackerpro.com/?add=slu-pp-332

### Sotatercept

High Evidence

Sotatercept (Winrevair, sotatercept-csrk) is Merck's first-in-class activin signaling inhibitor - a recombinant ActRIIA-Fc fusion protein that acts as a ligand trap for activin A, activin B, GDF-8 (myostatin) and GDF-11. It is FDA-approved for adults with pulmonary arterial hypertension (PAH), where it improved 6-minute walk distance by 40.8 meters in the Phase 3 STELLAR trial and, in the Phase 3 ZENITH trial in high-risk patients, cut the composite risk of death, lung transplantation and PAH hospitalization by 76%. An expanded U.S. label reflecting ZENITH was approved on October 27, 2025.

Cardiovascular: https://peptrackerpro.com/benefits/cardiovascular
Energy: https://peptrackerpro.com/benefits/energy
Rare Disease Treatment: https://peptrackerpro.com/benefits/rare-disease-treatment
Disease Modification: https://peptrackerpro.com/benefits/disease-modification

View Details: https://peptrackerpro.com/peptides/sotatercept

\+ Compare: https://peptrackerpro.com/compare?select=sotatercept
Track in App: https://app.peptrackerpro.com/?add=sotatercept

Track Your Research with PepTracker Pro

Try the Free App → (https://app.peptrackerpro.com/)